TaurelFinance, decoded
Live
Loading market data…
TTaurel

Ultragenyx sets $3.95 million price for rare disease gene therapy

Investing.com· Reuters· Sep 17, 2026 · 10:43 PM
Ultragenyx sets $3.95 million price for rare disease gene therapy

This is a summary. Read the complete story at Investing.com below.

Read full article at Investing.com

Related Stories

Google, Meta, TikTok sue to block California youth social media law
stocksabout 4 hours ago

Google, Meta, TikTok sue to block California youth social media law

Investing.com

Why is Oracle stock tumbling today?
stocksabout 4 hours ago

Why is Oracle stock tumbling today?

Investing.com

Truist downgrades Nike to Sell, says rally ignores ongoing risks
stocksabout 4 hours ago

Truist downgrades Nike to Sell, says rally ignores ongoing risks

Investing.com